首页> 外文期刊>Antimicrobial agents and chemotherapy. >In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
【24h】

In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

机译:甲氧苄氨嘧啶-磺胺甲基异恶唑的体外杀菌活性以及与共利斯汀联用对耐碳青霉烯类鲍曼不动杆菌的临床分离株的体外杀菌活性

获取原文
获取原文并翻译 | 示例
           

摘要

Trimethoprim-sulfamethoxazole alone and combined with colistin was tested in vitro against six carbapenem-resistant Acinetobacter baumannii (CRAB) clinical strains. After 24 h, at achievable serum concentrations, trimethoprim-sulfamethoxazole effectively killed all strains, while colistin killed only one strain. Trimethoprim-sulfamethoxazole plus colistin rapidly killed all strains after 6 h and for up to 24 h. Trimethoprim-sulfamethoxazole, one of the few remaining antimicrobials that still has a degree of activity, particularly combined with colistin, might represent an effective therapy for severe CRAB infections.
机译:单独对甲氧苄氨嘧啶磺胺甲基异恶唑和粘菌素进行了体外测试,针对六种对碳青霉烯耐药的鲍曼不动杆菌(CRAB)临床菌株进行了测试。 24小时后,在可达到的血清浓度下,甲氧苄啶-磺胺甲基异恶唑有效杀死了所有菌株,而粘菌素仅杀死了一个菌株。甲氧苄氨嘧啶磺胺甲基异恶唑加粘菌素迅速杀死所有菌株,并持续6 h。甲氧苄氨嘧啶磺胺甲基恶唑是少数仍具有一定活性,特别是与粘菌素合用的抗微生物药物之一,可能代表了一种针对严重CRAB感染的有效疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号